U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will be featured alongside other top doctors in the upcoming webinar summit, the Fix for Female Hormones.
September 26, 2018
· 3 min read